These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7576461)

  • 1. Microbial transformation of N-heptyl physostigmine, a semisynthetic alkaloid inhibitor of cholinesterase.
    So L; White R; Arison B; Petuch B; Schwartz MS; Cheng H; Monaghan R; Chen TS
    J Ind Microbiol; 1995 Aug; 15(2):108-11. PubMed ID: 7576461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease.
    Greig NH; Pei XF; Soncrant TT; Ingram DK; Brossi A
    Med Res Rev; 1995 Jan; 15(1):3-31. PubMed ID: 7898167
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates.
    Rupniak NM; Tye SJ; Brazell C; Heald A; Iversen SD; Pagella PG
    J Neurol Sci; 1992 Feb; 107(2):246-9. PubMed ID: 1564524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physostigmine analogs anticholinesterases: effects of the lengthening of the N-carbamic chain on the inhibition kinetics.
    Marta M; Gatta F; Pomponi M
    Biochim Biophys Acta; 1992 Apr; 1120(3):262-6. PubMed ID: 1576152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
    De Sarno P; Pomponi M; Giacobini E; Tang XC; Williams E
    Neurochem Res; 1989 Oct; 14(10):971-7. PubMed ID: 2608162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid potentiometric determination of cholinesterases in plasma and red cells: application to eptastigmine monitoring.
    Cazzola E; Lattuada N; Zecca L; Radice D; Luzzana M; Imbimbo BP; Auteri A; Mosca A
    Chem Biol Interact; 1993 Jun; 87(1-3):265-8. PubMed ID: 8343985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze.
    Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
    Neurosci Lett; 1992 Sep; 144(1-2):79-83. PubMed ID: 1436716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of acetylcholinesterase by physostigmine analogs: conformational mobility of cysteine loop due to the steric effect of the alkyl chain.
    Gavuzzo E; Pomponi M
    J Biochem Mol Toxicol; 2002; 16(2):64-9. PubMed ID: 11979423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenserine Axonyx.
    Thatte U
    Curr Opin Investig Drugs; 2005 Jul; 6(7):729-39. PubMed ID: 16044670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents.
    Dawson GR; Bentley G; Draper F; Rycroft W; Iversen SD; Pagella PG
    Pharmacol Biochem Behav; 1991 Aug; 39(4):865-71. PubMed ID: 1763105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers.
    Imbimbo BP; Licini M; Schettino M; Mosca A; Onelli E; Zecca L; Giustina A
    J Clin Pharmacol; 1995 Mar; 35(3):285-90. PubMed ID: 7608318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial transformation of L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease.
    Chen TS; Doss GA; Hsu A; Hsu A; Lingham RB; White RF; Monaghan RL
    J Nat Prod; 1993 May; 56(5):755-61. PubMed ID: 8326323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.
    Ul-Haq Z; Mahmood U; Jehangir B
    Chem Biol Drug Des; 2009 Dec; 74(6):571-81. PubMed ID: 19843075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds.
    Brossi A; Schönenberger B; Clark OE; Ray R
    FEBS Lett; 1986 Jun; 201(2):190-2. PubMed ID: 3709808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML
    Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
    Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
    J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternariol, a new fungal anticholinesterase drug. I.
    Mohammed YS; Osman M; Gabr Y
    Arzneimittelforschung; 1974 Jan; 24(1):121-2. PubMed ID: 4406099
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.
    Greig NH; Sambamurti K; Yu QS; Brossi A; Bruinsma GB; Lahiri DK
    Curr Alzheimer Res; 2005 Jul; 2(3):281-90. PubMed ID: 15974893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.